carbamazepine epoxide has been researched along with Benign Psychomotor Epilepsy, Childhood in 4 studies
carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Post, RM | 1 |
| Uhde, TW | 1 |
| Wolff, EA | 1 |
| Gidal, BE | 1 |
| Spencer, NW | 1 |
| Maly, MM | 1 |
| Pitterle, ME | 1 |
| Theodore, WH | 1 |
| Narang, PK | 1 |
| Holmes, MD | 1 |
| Reeves, P | 1 |
| Nice, FJ | 1 |
| Rapeport, WG | 1 |
1 review available for carbamazepine epoxide and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy.
Topics: Brain Chemistry; Carbamazepine; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, | 1985 |
1 trial available for carbamazepine epoxide and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
Topics: Biotransformation; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; D | 1984 |
2 other studies available for carbamazepine epoxide and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
Topics: Adult; Blood Proteins; Carbamazepine; Epilepsies, Partial; Epilepsy, Temporal Lobe; Female; Humans; | 1996 |
Carbamazepine and its epoxide: relation of plasma levels to toxicity and seizure control.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; | 1989 |